Outcome after curative resection for a huge (≥10 cm) hepatocellular carcinoma and prognostic significance of gross tumor classification

被引:98
作者
Choi, Gi Hong [1 ,2 ]
Han, Dai Hoon [1 ,2 ]
Kim, Dong Hyun [1 ,2 ]
Choi, Sae Byeol [1 ,2 ]
Kang, Chang Moo [1 ,2 ]
Kim, Kyung Sik [1 ,2 ]
Choi, Jin Sub [1 ,2 ]
Park, Young Nyun [2 ,3 ]
Park, Jun Yong [2 ,4 ]
Kim, Do Young [2 ,4 ]
Han, Kwang-Hyub [2 ,4 ]
Chon, Chae Yoon [2 ,4 ]
Lee, Woo Jung [1 ,2 ]
机构
[1] Yonsei Univ Hlth Syst, Dept Surg, Seoul 120752, South Korea
[2] Yonsei Univ Hlth Syst, Dept Internal Med, Seoul 120752, South Korea
[3] Yonsei Univ Hlth Syst, Dept Pathol, Seoul 120752, South Korea
[4] Yonsei Univ Hlth Syst, Yonsei Liver Canc Special Clin, Seoul 120752, South Korea
关键词
Hepatocellular carcinoma; Huge; Surgical resection; Prognosis; Gross tumor type; HEPATIC RESECTION; SURGICAL-TREATMENT; LARGER; MANAGEMENT; RECURRENCE; INVASION; SELECTION; SURVIVAL; SURGERY; RISK;
D O I
10.1016/j.amjsurg.2008.09.019
中图分类号
R61 [外科手术学];
学科分类号
摘要
BACKGROUND AND OBJECTIVES: The purpose of this study was to investigate the surgical outcomes in patients with huge (>= 10 cm.) hepatocellular carcinoma (HCC). METHODS: Clinicopathological features and surgical Outcomes of 50 patients with huge HCC who underwent curative resection (group A) were compared with 447 patients with smaller tumors (group 13). In group A, we investigated prognostic factors. RESULTS: Group A patients had a higher incidence of alpha-fetoprotein at more than 1,000 IU/mL microscopic vascular invasion, and advanced stage tumors. The disease-free survival of group A was significantly worse than group B. The rates of initial extrahepatic recurrence and early recurrence were higher in group A. The 5 year-overall survival of group A was 40.2%, significantly lower than that of group B (65.9% at 5 years). In group A. multivariate analysis revealed that the presence of single nodular type tumors was the only good prognostic factor for survival. CONCLUSIONS: Huge HCCs exhibit a more aggressive clinical behavior and worse survival. However, because the outcome of surgical treatment is far better than that Of nonsurgical treatment, resection should be actively considered for patients with huge HCC. A single nodular type tumor is the best candidate for surgical resection. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:693 / 701
页数:9
相关论文
共 36 条
[1]  
Abdel-Wahab M, 2001, HEPATO-GASTROENTEROL, V48, P757
[2]   Management of hepatoceullular carcinoma [J].
Bruix, J ;
Sherman, M .
HEPATOLOGY, 2005, 42 (05) :1208-1236
[3]   Clinical management of hepatocellular carcinoma.: Conclusions of the Barcelona-2000 EASL Conference [J].
Bruix, J ;
Sherman, M ;
Llovet, JM ;
Beaugrand, M ;
Lencioni, R ;
Burroughs, AK ;
Christensen, E ;
Pagliaro, L ;
Colombo, M ;
Rodés, J .
JOURNAL OF HEPATOLOGY, 2001, 35 (03) :421-430
[4]   Liver resection for HCC with cirrhosis: Surgical perspectives out of EASL/AASLD guidelines [J].
Capussotti, L. ;
Ferrero, A. ;
Vigano, L. ;
Polastri, R. ;
Tabone, A. .
EJSO, 2009, 35 (01) :11-15
[5]   HEPATIC RESECTION FOR A HEPATOCELLULAR-CARCINOMA LARGER THAN 10 CM [J].
FURUTA, T ;
SONODA, T ;
MATSUMATA, T ;
KANEMATSU, T ;
SUGIMACHI, K .
JOURNAL OF SURGICAL ONCOLOGY, 1992, 51 (02) :114-117
[6]   Cell motility mediated by Rho and Rho-associated protein kinase plays a critical role in intrahepatic metastasis of human hepatocellular carcinoma [J].
Genda, T ;
Sakamoto, M ;
Ichida, T ;
Asakura, H ;
Kojiro, M ;
Narumiya, S ;
Hirohashi, S .
HEPATOLOGY, 1999, 30 (04) :1027-1036
[7]   Predictive value of gross classification of hepatocellular carcinoma on recurrence and survival after hepatectomy [J].
Hui, AM ;
Takayama, T ;
Sano, K ;
Kubota, K ;
Akahane, M ;
Ohtomo, K ;
Makuuchi, M .
JOURNAL OF HEPATOLOGY, 2000, 33 (06) :975-979
[8]   Gross appearance of hepatocellular carcinoma reflects E-cadherin expression and risk of early recurrence after surgical treatment [J].
Inayoshi, J ;
Ichida, T ;
Sugitani, S ;
Tsuboi, Y ;
Genda, T ;
Honma, N ;
Asakura, H .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2003, 18 (06) :673-677
[9]  
KANAI T, 1987, CANCER-AM CANCER SOC, V60, P810, DOI 10.1002/1097-0142(19870815)60:4<810::AID-CNCR2820600417>3.0.CO
[10]  
2-1